The Active Humidifier Devices Market generated a revenue of USD 1,558.6 million in 2022. It is gradually declining at a (-) 0.5% CAGR, thus recording USD 1,264.4 million in 2023. By 2033, the market is expected to be contracted to USD 1,206.9 million, as forecasted by Future Market Insights.
Demand for active humidifier devices is mostly driven by the increased prevalence of obstructive respiratory diseases. Due to the outbreak of previously unknown infectious diseases that affect respiratory systems, the adoption of active humidifier devices surged in the historical period. Further, the application of humidifier devices in invasive ventilation accounted for nearly 47% of sales in 2022.
Attribute | Details |
---|---|
Active Humidifier Devices Market Size (2023) | USD 1,264.4 million |
Active Humidifier Devices Market Size (2033) | USD 1,206.9 million |
Active Humidifier Devices Industry CAGR (2023 to 2033) | -0.5% CAGR |
Active Humidifier Devices Market Size (2022) | USD 1,558.6 million |
Active Humidifier Devices Market Size (2017) | USD 442 million |
Active Humidifier Devices Industry CAGR (2017 to 2022) | 28.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Refining healthcare infrastructure and surging medical expenditure by governments are expected to support to set up and usage of advanced medical devices across various institutes. These institutes include hospitals, ambulatory surgical centers, primary healthcare units, and sleep care institutes.
Technological advancements have led to the expanding use of active respiratory humidifiers across various applications across care. Apart from the general hospitals' wards to critical care units, bubble humidifiers are now being found compatible to be used in MRI settings.
Agreements, partnerships, and collaborations have surfaced as main growth strategies implemented by the leading players in the active humidifier devices industry. Followed by this, new product launches emerged as the second-leading strategy adopted by the key players in the market. Further, these strategies help the companies to expand their product offerings to enhance respiratory care. Acquisitions of key companies significantly accelerate the manufacturer’s plan to capture more market share.
Improvement and streamlining of regulatory processes in developing countries are expected to boost
The manufacturers are realizing the low returns in this market despite these opportunities, considering the gradually reducing market size. Without beneficial prospects, manufacturers are most likely to turn down development proposals.
According to Future Market Insights (FMI), the sales of active humidifier devices market expanded at a CAGR of 28.7% between 2018 and 2022. During this period, the growing respiratory distress due to the COVID-19 virus had created a sharp rise in the adoption of ventilators the world over.
Demand for active humidifier devices increased during the pandemic as humidifiers are deployed to offer humidified air to patients who need respiratory assistance. Increased demand for crucial life-saving instruments such as medical ventilators, and high-flow oxygen therapy devices due to the sudden outbreak of COVID-19 motivated the market growth in the historical period.
The emergence of infectious diseases affecting respiratory systems and acceptance of high-flow nasal cannulas for oxygen therapy is anticipated to sustain the sales of active humidifier devices over the forecast period. Moreover, demand for active humidifier devices is primarily driven by improving healthcare infrastructure, increasing medical expenditure, and the high prevalence of respiratory diseases across the globe.
Integration of technologically advanced new solutions to meet patients' expanding respiratory needs is a primary reason for the intense competition in the market worldwide. Leading companies are concentrating on product unveilings and innovations or obtaining approvals for their new products to generate reasonable revenues.
Key manufacturers in this industry are hit severely since COVID cases have petered out. According to Future Market Insights, the global active humidifier devices industry is poised to register a CAGR of -0.5% from 2023 to 2033.
Historical CAGR (2018 to 2022) | 28.7% |
---|---|
Forecast CAGR (2023 to 2033) | -0.5% |
The market forecast is expected to be challenging for manufacturers, as the sales have been estimated to dwindle from USD 1,264.4 million in 2023 to USD 1,206.9 million by 2033.
The shriveling market size can be credited to the ease of COVID-19 cases. Other factors that are also contributing to the declining market include:
Strict Protocols to Restrict Infections: Strict infection control protocols for active humidifier devices to protect against dissemination of pathogens might restrict product’s uptake in healthcare setup. These devices require daily cleaning and maintenance to ascertain that they don’t become a breeding ground for contamination. Thus, increasing the workload for healthcare staff.
Cost Factor: Buying active humidifier devices is a costly affair, taking into account its operation and maintenance. Healthcare facilities with a limited budget are expected to reduce the probability of adoption of advanced active humidification systems, possibly jeopardizing patient care and outcome.
Requirement for Training: To properly use active humidifier devices, the healthcare personnel requires to be appropriately trained on the use, troubleshooting, and maintenance of these devices. However, proper training requires time and resources, which is challenging to procure in busy healthcare environments.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Country | The United States |
---|---|
Market Share % (2022) | 27.8% |
In 2022, the United States accounted for over 94% value share in North America. The need for active humidifier devices saw heightened demand in the United States due to the unprecedented outbreak of COVID-19.
A large number of patients suffering from COVID-19 have driven the need for active humidifier devices for survival. Due to the significant need for these devices, the market witnessed positive growth during the historical period.
The market is projected to be driven by rising affordability to treat respiratory diseases, an increasing number of tracheostomies executed for different diseases and health consciousness.
Country | Germany |
---|---|
Market Share % (2022) | 4% |
Germany is expected to account for over 32.3% of the market in Europe by 2033, opines Future Market Insights. The rise in demand for active humidifier devices is primarily due to increasing health awareness.
The sudden outbreak of the COVID-19 epidemic increased the demand for active humidifier diseases to curb the increasing mortality rates due to the pandemic. Further, the technological advancements and the adoption of heated/electronic humidifier devices are likely to offer up new opportunities for the active humidifier devices industry players in Germany.
Country | China |
---|---|
Market CAGR % (2023 to 2033) | 1.5% |
As per Future Market Insights, China’s active humidifier devices market is expected to account for over 49.5% of the market across East Asia by 2033. The high prevalence of respiratory diseases in the country is a key factor driving market growth.
Demand for active humidifier devices witnessed a sudden spike in the historical period as China was the first country to witness the spread of COVID-19. With surged cases, the need for active humidifier devices increased, spurring sales during that period.
In China, chronic respiratory diseases are the second leading cause of death. A few key factors propelling the market growth include a robust healthcare system and increasing healthcare expenditures and technological advancement.
Country | India |
---|---|
Market CAGR % (2023 to 2033) | -1.3% |
The active humidifier devices market in India is likely to register a CAGR of -1.3% during the forecast period, with a market share of over 50% across South Asia, as per the latest report of FMI. The leading factor that aided the market growth is the outbreak of the COVID-19 pandemic.
India witnessed a sudden spike in cases in the second wave, due to which the government increased the adoption of active humidifier devices to reduce the fatalities in the country.
Cases of coronavirus have abated in the country, leading to reduced demand for active humidifier devices. As a result, the country offers reduced opportunities for future growth. By the end of the forecast period, the market is expected to return to pre-covid levels.
Segment | Electronic Humidifiers |
---|---|
Market Share % (2022) | 55.79% |
With the advent of advanced technology and innovation in recent years, active humidifier devices are growing and have become one of the most significant sectors in the healthcare industry. Based on product type, heated/electronic humidifier devices are expected to lead the segment in the global market, occupying a market share of more than 55.79% by the end of 2023.
Demand for heated/electronic heaters is expected to increase over the coming years as electric humidifiers also help people with dry skin and allergies. Moreover, the high prevalence of airborne diseases such as flu, influenza, and other diseases has surged the adoption of heated/electronic humidifier devices.
Medical researchers found that humidity levels above 40% significantly deactivate the virus and bacteria that cause airborne respiratory diseases. Hence, adoption of these devices is expected to surge over the coming years.
Segment | Invasive Ventilation |
---|---|
Market Share % (2022) | 47% |
By application, the market is segregated into non-invasive ventilation, invasive ventilation, and high-flow oxygen therapy. As per Future Market Insights, the invasive ventilation segment is expected to be the dominant segment in the global active humidifier devices market in 2023, occupying a market share of more than 47% in 2023.
Following the outbreak of COVID-19, as the cases increased at an alarming rate, especially in developing economies such as India, the need for invasive ventilation increased the sales of active humidifier devices. Also, the demand for non-invasive ventilation among the geriatric population is expected to increase over the coming years. The segment is projected to account for over 31.3% of the market share by 2033.
Companies operating in the global active humidifier devices industry seek to invigorate their position through collaborations, partnerships, and agreements with established and emerging market players. Further, the acquisition significantly accelerates the manufacturer’s strategy to capitalize on the market share and capture a significant share of the market.
Key Developments Taking Place in the Market:
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Market Analysis | USD million for Value, Units for Volume |
Key Countries Covered | The United States, Canada, Germany, the United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, South Africa |
Key Segments Covered | Product Type, Age Group, Application, End User, and Region |
Key Companies Profiled | Fisher & Paykel Healthcare Limited; Koninklijke Philips N.V.(Philips Respironics); Vapotherm; Teleflex Corporation; ResMed Corporation; VINCENT MEDICAL HOLDINGS LIMITED; Armstrong Medical (an Eakin Company); Breas Medical AB (Subsidiary of Fosun Pharma); BMC Medical Co., Ltd; Hamilton Medical AG; SunMed; WILAmed GmbH; Flexicare (Group) Limited; Penlon Limited; DEAS S.R.L.; Intersurgical Ltd; Beijing Aeonmed Co., Ltd.; Shenyang RMS MEDICAL TECH CO., LTD; GaleMed Corporation; Vadi Medical Technology Co, Ltd. |
Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
The active humidifier devices market CAGR for 2033 is -0.5%.
The market is estimated to reach USD 1,206.9 million by 2033.
The challenges in the active humidifier devices market are the cost, maintenance, and risk of mold growth.
The market is estimated to secure a valuation of USD 1,264.4 million in 2023.
Increasing demand for indoor air quality improvement is the key challenge.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Heated/electronic Humidifiers 5.2. Bubble Humidifiers 5.3. Accessories 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Age Group 6.1. Adult 6.2. Paediatric 6.3. Neonates 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 7.1. Invasive Ventilation 7.2. Non-invasive Ventilation 7.2.1. nCPAP (Nasal Continuous Positive Airway Pressure) 7.2.2. Bubble CPAP (Bubble Continuous Positive Airway Pressure) 7.3. High Flow Oxygen Therapy 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 8.1. Hospitals 8.1.1. Less than 100 Beds 8.1.2. 100-300 Beds 8.1.3. 300-500 Beds 8.1.4. 500 Beds and More 8.2. Ambulatory Surgical Centers 8.3. Sleep Centres 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. Eastern Europe 9.5. South Asia and Pacific 9.6. East Asia 9.7. Middle East and Africa 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 17. Key Countries Market Analysis 18. Market Structure Analysis 19. Competition Analysis 19.1. Fisher & Paykel Healthcare Limited 19.2. Koninklijke Philips N.V. (Philips Respironics) 19.3. Vapotherm 19.4. Teleflex Corporation 19.5. ResMed Corporation 19.6. VINCENT MEDICAL HOLDINGS LIMITED 19.7. Armstrong Medical (an Eakin Company) 19.8. Breas Medical AB (Subsidiary of Fosun Pharma) 19.9. BMC Medical Co., Ltd 19.10. Hamilton Medical AG 19.11. SunMed 19.12. WILAmed GmbH 19.13. Flexicare (Group) Limited 19.14. Penlon Limited 19.15. DEAS S.R.L. 19.16. Intersurgical Ltd 19.17. Beijing Aeonmed Co., Ltd. 19.18. Shenyang RMS MEDICAL TECH CO., LTD 19.19. GaleMed Corporation 19.20. Vadi Medical Technology Co., Ltd. 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports